About clinical trials

The basics of research

A clinical trial is a type of medical research that works to answer specific questions, such as:

  • Is the investigational therapy safe?
  • Does the investigational therapy work?

Like many clinical trials, the FREEDOM-3 trial will focus on learning more about a potential treatment to see if it could help people with a specific disease or condition—in this case, people who have dcSSc.

Could you take part?

Take a short survey to find out if you could qualify for the FREEDOM-3 clinical trial.

Models pictured are not actual participants
in the FREEDOM-3 trial.

Research safety

Participant safety is the most important part of any trial.

Before any clinical trial can begin, institutional review boards (IRBs) review the trial to ensure that the rights, welfare, and safety of all trial participants will be protected. The FREEDOM-3 trial has been approved by IRBs at all of the trial sites.

During the trial, participants’ health is closely monitored by the study team. If their health gets worse, the study team will decide the safest way to continue, which could include changing to a different medication or leaving the trial completely.

What does the phase of a trial mean?

Before a treatment can be approved to be used by the public, it must go through several stages of research called phases.

Phase 1

A small group of healthy people are given the investigational therapy to learn about the dose and potential side effects.

Phase 2

A larger group of people with the condition being studied are given the investigational therapy to learn if it could be safe and effective.

The FREEDOM-3 clinical trial is a combination of the above phases (phase 1/2a).

Phase 3

An even larger group of people with the condition being studied are given the investigational therapy to learn if it could be safe and effective, and to compare it against existing treatments (the standard of care) or a placebo (a fake drug).

Treatment reviewed by the FDA.
Phase 4

These trials take place once an investigational therapy has been approved for use. They help us learn how the treatment affects people in the long-term.

Definitions

Some terms you may hear during the FREEDOM-3 trial and what they mean.

Investigational cell therapy

The investigational cell therapy being researched in the FREEDOM-3 clinical trial is called FCR001. FCR001 is administered intravenously (given into the vein) as a one-time infusion. Investigational means it is still being developed and has not been approved by the FDA for use by the general public.

Standard of care

A currently approved treatment plan for a specific condition. For people with dcSSc, this is usually immunosuppressive medicines.

Assessments

Health checks that take place during clinic visits. In the FREEDOM-3 clinical trial, these can include things like blood draws, physical exams, and skin biopsies. Your study team will talk you through what to expect at each visit.

Informed consent

Before you decide to take part in a trial, you will receive an informed consent form to read and sign to ensure you understand the trial in full. The form describes what you should expect from the trial, including timelines, procedures and assessments, and potential risks and benefits of taking part. The study team will discuss this with you in more detail and answer any questions you may have.

Protocol

The written plan that describes the trial in detail, including the need for the trial, who can take part, and what happens at every clinic visit.

The FREEDOM-3 trial

Explore the details of the FREEDOM-3 clinical trial.

Models pictured are not actual participants
in the FREEDOM-3 trial.